Regulatory and pathogenetic mechanisms of autoantibodies in SLE

In the 53 years since the discovery of anti-DNA autoantibodies in lupus [1, 2, 3], recalcitrant questions have been pondered and possible answers have been debated. The discovery of anti-DNA autoantibodies presented many puzzles: How is immunological tolerance to native B-form DNA broken? What elici...

Full description

Saved in:
Bibliographic Details
Published in:Autoimmunity (Chur, Switzerland) Switzerland), 2011-08, Vol.44 (5), p.349-356
Main Authors: Radic, Marko, Herrmann, Martin, van der Vlag, Johan, Rekvig, Ole Petter
Format: Article
Language:English
Subjects:
Animals
Animals, Genetically Modified
anti-DNA antibodies
Antibodies, Antinuclear - immunology
Antibodies, Antinuclear - metabolism
apoptosis
autoantibodies
Autoantigens - immunology
B cell regulation
B-Lymphocytes - cytology
B-Lymphocytes - immunology
B-Lymphocytes - metabolism
Cell Death - immunology
Disease Models, Animal
Glomerulonephritis - etiology
Glomerulonephritis - immunology
Glomerulonephritis - metabolism
Humans
Lupus Erythematosus, Systemic - complications
Lupus Erythematosus, Systemic - genetics
Lupus Erythematosus, Systemic - immunology
Lupus Erythematosus, Systemic - therapy
Mice
Systemic lupus erythematosus
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the 53 years since the discovery of anti-DNA autoantibodies in lupus [1, 2, 3], recalcitrant questions have been pondered and possible answers have been debated. The discovery of anti-DNA autoantibodies presented many puzzles: How is immunological tolerance to native B-form DNA broken? What elicits characteristic systemic lupus erythematosus (SLE) autoantibodies? Which of the diverse anti-nuclear reactivities are pathogenic? What is the role of autoantibodies in the clinical presentation of disease? How do genetic predisposition and environmental triggers contribute to SLE? These questions were brought into focus by Professor David Stollar in an introductory presentation to an intense, three-day meeting set among the rugged and inspiring scenery of the Norwegian arctic coastline (the Scientific Program is included as supplemental File 1). Other participants presented and discussed topics directed to understanding the origin and clinico-pathological impact of autoantibodies to chromatin and phospholipid antigens. In the following, several aspects of the workshop are discussed.
ISSN:0891-6934
1607-842X
DOI:10.3109/08916934.2010.536794